日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the mechanism of endothelial Pim-1 upregulation of tissue factor to initiate the hypercoagulable state in sepsis.

探索内皮细胞 Pim-1 上调组织因子以启动脓毒症高凝状态的机制。

Wang Qing, Hong Yun, Wang Ying, Zhang Rongrong, Zhou Chen, Pan Jingye

Editorial Expression of Concern: Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1

社论关注:链脲佐菌素(STZ)诱导的雌性糖尿病小鼠快速发生心肌病与促生存蛋白Pim-1的下调有关

Moore, Andrew; Shindikar, Amol; Fomison-Nurse, Ingrid; Riu, Federica; Munasinghe, Pujika E; Ram, Thrishila Parshu; Saxena, Pankaj; Coffey, Sean; Bunton, Richard W; Galvin, Ivor F; Williams, Michael J A; Emanueli, Costanza; Madeddu, Paolo; Katare, Rajesh

Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1 [Retraction]

Ventilagolin通过下调Pim-1抑制肝细胞癌细胞的迁移、侵袭和上皮-间质转化[撤稿]

Unravelling the potency of the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S-arylamide hybrids as PIM-1 kinase inhibitors: synthesis, biological activity and in silico studies.

揭示 4-氧代-2-硫代-1,2,3,4-四氢嘧啶-5-腈骨架与 S-芳酰胺杂合物作为 PIM-1 激酶抑制剂的效力:合成、生物活性和计算机模拟研究。

Molecular insights and inhibitory dynamics of flavonoids in targeting Pim-1 kinase for cancer therapy

黄酮类化合物靶向Pim-1激酶的分子机制及其抑制动力学在癌症治疗中的应用

Alhadrami, Hani A; Sayed, Ahmed M; Hassan, Hossam M; Alhadrami, Albaraa H; Rateb, Mostafa E

Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity

设计、合成、生物学评价和分子对接研究新型三唑并[4,3-b]哒嗪衍生物作为具有抗肿瘤活性的双重c-Met/Pim-1潜在抑制剂。

Mahmoud, Mohamed E; Ahmed, Eman M; Ragab, Hamdy M; Eltelbany, Rania Farag A; Hassan, Rasha A

The impact of MYD88 and PIM1 in mature large B-cell non-Hodgkin lymphomas: Defining element of their evolution and prognosis

MYD88 和 PIM1 对成熟大 B 细胞非霍奇金淋巴瘤的影响:其演变和预后的决定因素

Miruna Cristian, Mariana Așchie, Anca-Florentina Mitroi, Mariana Deacu, Mădălina Boșoteanu, Gabriela-Izabela Bălțătescu, Andreea-Georgiana Stoica, Anca-Antonela Nicolau, Manuela Enciu, Ana-Maria Crețu, Andreea-Daniela Caloian, Cristian-Ionuț Orășanu, Ionuț Poinăreanu

Correction to 'In vivo analysis of Pim-1 deficiency'

对“Pim-1 缺陷的体内分析”的更正

Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation

基于氰基吡啶酮和氰基吡啶的癌细胞Pim-1抑制剂:设计、合成、放射性标记、生物分布和分子建模模拟

Mansour, Basem; Salem, Yomna A; Attallah, Khaled M; El-Kawy, O A; Ibrahim, Ismail T; Abdel-Aziz, Naglaa I

Correction: Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma

更正:Pim-1在人类唾液腺腺样囊性癌中发挥癌基因的作用

Zhu, Xin; Xu, Jia-Jie; Hu, Si-Si; Feng, Jian-Guo; Jiang, Lie-Hao; Hou, Xiu-Xiu; Cao, Jun; Han, Jing; Ling, Zhi-Qiang; Ge, Ming-Hua